Companies In the News
Authors:
Date:
PRNewswire: August 24, 2017 – BOONTON, NJ, U.S.A. – Enteris BioPharma, Inc., a biotechnology company developing innovative drug products built around its proprietary delivery technologies, announced today that the first woman has been dosed in its phase 2a clinical trial to evaluate Ovarest™, an…
Authors:
Date:
PRNewswire: August 24, 2017 – WILSON, WY, U.S.A. – SynAgile Corporation (www.synagile.com), a privately held pharmaceutical company that develops and commercializes drug delivery systems using its proprietary OraFuse™ technology platform, today announced the closing of a $10.4 million round of…
Authors:
Date:
PRNewswire: August 24, 2017 – SOUTH SAN FRANCISCO, CA, U.S.A. – Titan Pharmaceuticals, Inc. (NASDAQ: TTNP) announced today that the U.S. Food and Drug Administration (FDA) has cleared the Investigational New Drug (IND) application for its ropinirole implant intended for treatment of the signs and…
Authors:
Date:
PRNewswire: August 22, 2017 – SAN JOSE, CA, U.S.A. – Teikoku Pharma USA, Inc. (Teikoku Pharma) today announced positive topline results from its phase 2 proof of concept study of TPU-006, a 3-day dexmedetomidine transdermal patch, a novel drug delivery system with a nonopioid active moiety for the…
Authors:
Date:
PRNewswire: August 18, 2017 – WASHINGTON, DC, U.S.A. – An article published in Experimental Biology and Medicine (volume 242, issue 14, August 2017) reports that a plant virus–based system can be used to deliver anticancer drugs. The study, led by Dr. Nicole Steinmetz in the Department of…
Authors:
Date:
PRNewswire: August 15, 2017 – PISCATAWAY, NJ, U.S.A. – PuraCap® Pharmaceutical today introduced the EpiCeram® controlled release skin barrier emulsion quad pack, which contains 400 g of eczema relief. EpiCeram® is an FDA-approved topical prescription emollient used to treat dry skin conditions and…
